Callan Family Office’s Arch Capital ACGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
20,184
-440
-2% -$41.5K 0.04% 400
2026
Q1
$1.98M Sell
20,624
-25
-0.1% -$2.39K 0.04% 356
2025
Q4
$1.98M Buy
20,649
+15,829
+328% +$1.45M 0.04% 353
2025
Q3
$437K Sell
4,820
-4,572
-49% -$410K 0.01% 570
2025
Q2
$855K Buy
9,392
+6,960
+286% +$642K 0.03% 434
2025
Q1
$234K Sell
2,432
-125
-5% -$11.5K 0.02% 494
2024
Q4
$236K Buy
+2,557
New +$258K 0.02% 562

Other funds holding ACGL

Callan Family Office's ACGL Position: Q2 2026 in Review

Callan Family Office reduced its Arch Capital (ACGL) stake by 2.1% in Q2 2026, selling an estimated $41.5K and leaving 20,184 shares worth $1.96M. The position accounts for 0.04% of the portfolio, ranked #400.

Callan Family Office first reported a position in ACGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.98M in Q4 2025. 906 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.

  • Callan Family Office held 20,184 shares of Arch Capital worth $1.96M as of Q2 2026.
  • Callan Family Office sold 440 Arch Capital shares in Q2 2026, an estimated $41.5K.
  • Arch Capital made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #400 holding.
  • Callan Family Office first reported a position in Arch Capital in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Arch Capital position peaked at $1.98M in Q4 2025.
  • 906 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.